Abstract:Background: Metastasis is one of the main reasons for the high mortality associated with pancreatic ductal adenocarcinoma (PDAC), and autophagy regulates the metastatic migration of tumor cells, their invasion of tissues, and their formation of focal adhesions. Inhibiting autophagy may suppress tumor growth and metastasis, but the abundant extracellular matrix hinders the deep penetration of therapeutic agents. Methods: To enhance the penetration of drugs that can inhibit metastasis of pancreatic cancer, a pH-responsive drug delivery system was formulated. Gemcitabine (GEM), a first-line chemotherapeutic drug against PDAC, was loaded in 6PA-modified DGL (PDGL) nanoparticles to afford PDGL-GEM. Then PDGL-GEM was co-precipitated with the autophagy inhibitor chloroquine phosphate (CQ) and calcium phosphate to formulate PDGL-GEM@CAP/CQ. The size and morphology of the resulting "nanobomb" PDGL-GEM@CAP/CQ were characterized, and their uptake into cells, cytotoxicity and ability to inhibit autophagy were analyzed at pH 6.5 and 7.4. The anti-tumor and anti-metastasis effects of the nanobomb were explored on mice carrying Pan 02 pancreatic tumor xenografts or orthotopic tumors. Results: The pH-induced dissolution of calcium phosphate facilitated the release of CQ from the nanobomb and deep penetration of PDGL-GEM. The internalization of PDGL-GEM and subsequent intracellular release of GEM inhibited tumor growth, while CQ downregulated autophagy in tumor cells and fibroblasts. In fact, inhibition of xenograft and orthotopic tumor growth was greater with the complete PDGL-GEM@CAP/CQ than with subassemblies lacking GEM or CQ. More importantly, mechanistic studies in vitro and in vivo suggested that the nanobomb inhibits metastasis by downregulating MMP-2 and paxillin, as well as reducing fibrosis. Conclusion: The pH-sensitive PDGL-GEM@CAP/CQ shows potential for inhibiting proliferation and metastasis of pancreatic cancer through an autophagy-dependent pathway.

Carbamoylphosphonates inhibit autotaxin and metastasis formation in vivo

Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice

Synthesis and Activity of a Novel Autotaxin Inhibitor-Icodextrin Conjugate

Design, Synthesis and Promising Anti-Tumor Efficacy of Novel Imidazo [1,2-A]pyridine Derivatives As Potent Autotaxin Allosteric Inhibitors

A Novel Sulfonamide Agent, MPSP-001, Exhibits Potent Activity Against Human Cancer Cells in Vitro Through Disruption of Microtubule

Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models

Targeting the Mitochondria with Pseudo- Stealthy Nanotaxanes to Impair Mitochondrial Biogenesis for Effective Cancer Treatment

Novel Autotaxin Inhibitor ATX-1d Significantly Enhances Potency of Paclitaxel-An In Silico and In Vitro Study

Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy

Targeting Melanoma Growth and Viability Reveals Dualistic Functionality of the Phosphonothionate Analogue of Carba Cyclic Phosphatidic Acid

P2Y12 receptor-mediated cyclooxygenase 2 (COX-2) expression enhances tumor cell progression in a mouse model of lymphoma

Synthetic Paclitaxel-Octreotide Conjugate Reversing the Resistance of A2780/Taxol to Paclitaxel in Xenografted Tumor in Nude Mice

Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis

Inhibition Of Skeletal Growth Of Human Prostate Cancer By The Combination Of Docetaxel And Bkm1644, An Aminobisphosphonate Derivative

Co-delivery of Autophagy Inhibitor and Gemcitabine Using a Ph-Activatable Core-Shell Nanobomb Inhibits Pancreatic Cancer Progression and Metastasis.

Targeting PNPO to suppress tumor growth via inhibiting autophagic flux and to reverse paclitaxel resistance in ovarian cancer

KAI1/CD82gene and Autotaxin-Lysophosphatidic Acid Axis in Gastrointestinal Cancers

Trident Molecule with Nanobrush-Nanoparticle-Nanofiber Transition Property Spatially Suppresses Tumor Metastasis.

SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis

Anticancer Activity of Polyoxometalate-Bisphosphonate Complexes: Synthesis, Characterization, in Vitro and in Vivo Results.

Targeted Codelivery Of Docetaxel And Atg7 Sirna For Autophagy Inhibition And Pancreatic Cancer Treatment